Targeting FtsZ for antituberculosis drug discovery: noncytotoxic taxanes as novel antituberculosis agents

J Med Chem. 2006 Jan 26;49(2):463-6. doi: 10.1021/jm050920y.

Abstract

Screening of 120 taxanes identified a number of compounds that exhibited significant antituberculosis activity. Rational optimization of selected compounds led to the discovery that the C-seco-taxane-multidrug-resistance (MDR) reversal agents (C-seco-TRAs) are noncytotoxic at the upper limit of solubility and detection (>80 microM), while maintaining MIC(99) values of 1.25-2.5 microM against drug-resistant and drug-sensitive strains of Mycobacterium tuberculosis (MTB). Treatment of MTB cells with TRA 3aa and 10a at the MIC caused filamentation and prolongation of the cells, a phenotypic response to FtsZ inactivation.

Publication types

  • Comparative Study
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Actin Cytoskeleton / drug effects
  • Actin Cytoskeleton / ultrastructure
  • Antineoplastic Agents / pharmacology
  • Antitubercular Agents / chemical synthesis*
  • Antitubercular Agents / chemistry
  • Antitubercular Agents / pharmacology
  • Bacterial Proteins / antagonists & inhibitors*
  • Bacterial Proteins / chemistry
  • Biopolymers
  • Cytoskeletal Proteins / antagonists & inhibitors*
  • Cytoskeletal Proteins / chemistry
  • Drug Resistance, Multiple, Bacterial / drug effects
  • Microbial Sensitivity Tests
  • Mycobacterium tuberculosis / drug effects
  • Mycobacterium tuberculosis / ultrastructure
  • Paclitaxel / pharmacology
  • Structure-Activity Relationship
  • Taxoids / chemical synthesis*
  • Taxoids / chemistry
  • Taxoids / pharmacology

Substances

  • Antineoplastic Agents
  • Antitubercular Agents
  • Bacterial Proteins
  • Biopolymers
  • Cytoskeletal Proteins
  • FtsZ protein, Bacteria
  • Taxoids
  • Paclitaxel